Volume 17 - Issue 11 - November, 2005
08/01/2008
Michael R. Recto, MD; Walter L. Sobczyk, MD; Erle H. Austin, III, MD
The Fontan operation was first described for management of univentricular heart disease in 1971. Since it was first described, there have been several modifications to the original operation.1 In 1988, de Laval2 first proposed the concept of...
The Fontan operation was first described for management of univentricular heart disease in 1971. Since it was first described, there have been several modifications to the original operation.1 In 1988, de Laval2 first proposed the concept of...
The Fontan operation was first...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Qi-Ling Cao, MD; Lisa Shah, MD; Ziyad M. Hijazi, MD, MPH; Satindir K. Sandhu, MD; Annette Joseph, RN
Coarctation of the aorta (CoA) accounts for 6–8% of all forms of congenital heart defects. In children and adults, balloon angioplasty has become the preferred treatment for patients with recurrent CoA.1–5,6–18 The application of this...
Coarctation of the aorta (CoA) accounts for 6–8% of all forms of congenital heart defects. In children and adults, balloon angioplasty has become the preferred treatment for patients with recurrent CoA.1–5,6–18 The application of this...
Coarctation of the aorta (CoA)...
08/01/2008
Journal of Invasive Cardiology
Feature
Clinical Images
08/01/2008
Stéphane Cook, MD; David Tueller, MD
A 42-year-old man presented with heavy chest pain of four hours’ duration. Physical examination was unremarkable. The ECG showed an acute septoapical infarction. Nitroglycerin, aspirin, clopidogrel and heparin were administered, and an...
A 42-year-old man presented with heavy chest pain of four hours’ duration. Physical examination was unremarkable. The ECG showed an acute septoapical infarction. Nitroglycerin, aspirin, clopidogrel and heparin were administered, and an...
A 42-year-old man presented with...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
Uzeyir Rahimov, MD; Yusuf Atmaca, MD; Deniz Kumbasar, MD; Sadi Guleç, MD; Cetin Erol, MD; Cagdas Ozdol, MD
Myocardial injury after percutaneous coronary interventions has been recognized as a frequent and prognostically important event.1 Multiple institutions have now reported follow-up studies of percutaneous revascularization, and the evidence...
Myocardial injury after percutaneous coronary interventions has been recognized as a frequent and prognostically important event.1 Multiple institutions have now reported follow-up studies of percutaneous revascularization, and the evidence...
Myocardial injury after...
08/01/2008
Journal of Invasive Cardiology
Original Contribution
08/01/2008
David X. Zhao, MD; Douglas Vaughan, MD; Joseph G. Salloum, MD; Carter Tharpe, MD
The no-reflow phenomenon is defined as a severe reduction in antegrade coronary flow in the absence of epicardial vessel obstruction.1 The presence of no-reflow substantially increases the risk of major adverse clinical events (MACE) in...
The no-reflow phenomenon is defined as a severe reduction in antegrade coronary flow in the absence of epicardial vessel obstruction.1 The presence of no-reflow substantially increases the risk of major adverse clinical events (MACE) in...
The no-reflow phenomenon is...
08/01/2008
Journal of Invasive Cardiology
Insights
Commentary
08/01/2008
David G. Rizik, MD, FACC, FSCAI
Since Robert Goetz first performed a single mammary artery bypass to the anterior descending artery in 1960, its evolution has been associated with unparalleled clinical benefit in terms of symptom relief and a favorable effect on mortality,...
Since Robert Goetz first performed a single mammary artery bypass to the anterior descending artery in 1960, its evolution has been associated with unparalleled clinical benefit in terms of symptom relief and a favorable effect on mortality,...
Since Robert Goetz first...
08/01/2008
Journal of Invasive Cardiology
Commentary
08/01/2008
Pedro Martinezclark, MD; Joseph P. Carrozza, Jr., MD
Percutaneous intervention of saphenous vein grafts is associated with approximately 20% risk of major adverse cardiovascular events secondary to decreased antegrade flow or “no-reflow” during the procedure.1 The mechanism of this phenomenon...
Percutaneous intervention of saphenous vein grafts is associated with approximately 20% risk of major adverse cardiovascular events secondary to decreased antegrade flow or “no-reflow” during the procedure.1 The mechanism of this phenomenon...
Percutaneous intervention of...
08/01/2008
Journal of Invasive Cardiology
